Betalen wij dubbel voor onze geneesmiddelen? medischcontact.nl/opinie/blogs-c… via @medischcontact
Nederlands
HM3A Vivactis
11 posts
HM3A Vivactis
@Hm3aV
HM3A Vivactis is a #consultancy agency specialized in #market #access for #pharmaceutical and #medical devices. Based in Brussels, we network throughout Europe.
Brussels, Belgium Katılım Nisan 2019
0 Takip Edilen13 Takipçiler
read about patient rights and healtheconomics in Belgium lnkd.in/dzWzEgQ
English
‘Landmark’ day for Akcea as NICE recommends Tegsedi in rare inherited hATTR pharmatimes.com/news/landmark_…
English
I'm going to "MedTech Accelerator® 2019 : Discover Medtech innovations developed in your...". See you there? eventbrite.com/e/medtech-acce… via @Eventbrite
English
Catalyst shares dive amid speculation about ‘off-label’ rare disease rival pharmaphorum.com/?p=54393 via @pharmaphorum
English
UK government revamps efforts to hasten access to new drugs pharmaphorum.com/?p=54309 via @pharmaphorum
English
De vrouw die fake news over vaccins bestrijdt hln.be/de-krant/de-vr… via @HLN_BE
Nederlands
Drug middlemen point finger at pharma in US pricing debate disq.us/t/3diz3fi
English
HM3A Vivactis retweetledi
HM3A Vivactis new website is live !
Want information regarding #MarketAccess, #Public and #Governmental Affairs as well as #Regulatory Affairs and #RiskManagement services ?
Click here ➡️ hm3a.eu
English